New pill aims to ease heart failure Patients' urgent bathroom trips
NCT ID NCT06206512
Summary
This study tested if a new, longer-acting version of a common water pill (torsemide) could better control overactive bladder symptoms like frequent and urgent urination in people with chronic heart failure. It compared this extended-release version against the standard, immediate-release pill over two 4-week periods in 24 participants. The main goal was to see if the new version improved patients' quality of life related to their bladder symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cardiometabolic Research Unit
Dallas, Texas, 75390, United States
Conditions
Explore the condition pages connected to this study.